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Background: Sclerotherapy is a widely used method for the obliteration of blood vessels. Hyperpig-
mentation is a frequent complication that results from haemosiderin (FeO) accumulation. Hyperpig-
mentation and changes in the skin can be observed with ultrasound.
Objective: The aim of this study was to evaluate the efﬁcacy of hyperpigmentation elimination using an
intense pulse light generator (IPL) equipped with radio waves (RF) under ultrasonography (US) control.
Methods: Twenty-one women with permanent hyperpigmentation (after sclerotherapy or crossectomy
combined with sclerotherapy) underwent a hyperpigmentation eliminating therapy with the use of
IPL þ RF and were monitored by using US. The thicknesses of the dermis and the subcutaneous tissue as
well as the echogenicities of each layer were assessed.
Results: As a result of the therapy, a complete regression of hyperpigmentation was achieved in 90.48% of
the women, and in 9.52% of the women, the therapy led to a reduction in hyperpigmentation but did not
cause its complete disappearance. An increase in dermal echogenicity and a decrease in subcutaneous
tissue echogenicity were observed, but there was no change in their thicknesses. After the therapy, the
ultrasound images of areas of previous hyperpigmentation corresponded with images that were char-
acteristic of healthy skin.
Conclusion: IPL þ RF therapy is effective for eliminating permanent skin hyperpigmentation after scle-
rotherapy. US is also useful in this therapeutic method.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Sclerotherapy is a widely used method for the treatment of
teleangiectasia and reticular veins (below 3 mm in diameter) as
well as large veins (above 3 mm in diameter).1 Recently, scle-
rotherapy has been effectively used to treat chronic venous insuf-
ﬁciency alone or in combination with classical surgery or
endovascular methods.2 Despite numerous advantages, such as the
ease of operation, high efﬁciency and low cost, this method pres-
ents some possible complications. One of the most common
complications is the hyperpigmentation of the skin that can appear
at the site at which a sclerosing agent was administered or along
a vein treated by sclerotherapy.1,3 Hyperpigmentation occurs in
approximately 15e20% of patients who have been subjected to
sclerotherapy.4,5 In most cases, the hyperpigmentation disappears
spontaneously within several months after the procedure.1 Unfor-
tunately, the hyperpigmentation that appears within a short time01355236 (Mobile); fax: þ48
ciety for Vascular Surgery. Publisheafter the sclerotherapy is permanent in approximately 10% of
patients.4,6 The aetiology of post-sclerotherapy hyperpigmentation
still causes a lot of controversy.79 Various methods have been used
to remove post-sclerotherapy hyperpigmentation.7,10,11 Good
results were reported in cases in which a Q-switched ruby laser12
and a ﬂash lamp-excited laser were used, with wavelengths of
694 and 510 nm, respectively.13 However, these studies were con-
ducted on a very small group of subjects.
One of the latest pieces of equipment used for eliminating
hyperpigmentation is an intense pulse light generator (IPL). An IPL
is based on a high-energy lamp ﬁlled with gas, which is the source
of a non-coherent light beam, with a wavelength between 500 and
1300 nm.14,15 To obtain an adequate wavelength, ﬁlters are used to
block out the shorter wavelengths.14 In recent years, some IPL
generators have also been equipped with bipolar radio frequency
waves (RF). The combination of IPL þ RF in one device provides the
operator with the sophisticated synergistic action of the two
different energy types.16 IPL þ RF damages cells that contain
chromophores according the selective thermolysis rule15 andd by Elsevier Ltd. All rights reserved.
Table 1
The parameters used to remove hyperpigmentation using IPL þ RF therapy.
Parameters Skin phototype (Fitzpatrick scale) Average in all patients
I II III IV V VI
Number of patients [n] 8 11 2 0 0 0 21
Average minimum dose of IPL [J/cm2] 27.75 22 17.5 0 0 0 23.76
Average minimum dose of RF [W] 18.75 19.45 16.5 0 0 0 18.90
Average maximum dose of IPL [J/cm2] 37.25 30.09 24.5 0 0 0 32.29
Average maximum dose of RF [W] 28.88 28.88 27.5 0 0 0 28.33
Average number of treatments 7.375 6.645 8.5 0 0 0 7
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providing skin with elasticity and a normal appearance.17,18
Until now, no one has monitored the course of hyperpigmen-
tation elimination therapy using ultrasound, which is useful for the
evaluation of skin and subcutaneous tissue.1921
The purpose of this study was to evaluate the effectiveness of
eliminating hyperpigmentation using an IPL that was additionally
equipped with RF. Our study did not involve teleangiectasia
removal.Material and Methods
Study sample
The study sample consisted of 21 women aged 25e68 years; the
mean age was 48.95 years. All of the women included in the study
sample manifested permanent, that is, persisting for more than 18
months, hyperpigmentation located on their lower limbs. The
decision onwhether to include a patient inducted into the IPLþ RF-
assisted therapy was made based on the visual assessment of the
hyperpigmented skin area, the analysis of the disease history and
elimination due to contraindications to the therapy. When the
clinical progression of venous insufﬁciency according to Classiﬁ-
cation of Chronic Venous Insufﬁciency (CEAP) was considered, the
C1, C2 and C3 categories were ascribed to 7, 10 and 4 women,
respectively. Hyperpigmentation occurred in four, three and six
women who underwent sclerotherapy for teleangiectasia (spider
veins), reticular veins and collateral varicose veins, respectively. It
also occurred in eight cases of trunk obliteration e six patients
underwent sclerotherapy for the great saphenous vein (GSV) and
two patients for the small saphenous vein (SSV). The obliteration of
teleangiectasia, reticular veins and collateral varicose veins was
conducted using the Tournay method. This method is based on
injecting a sclerosing agent into a patient staying in a decubitus.
The obliteration is performed from the proximal to the distal
direction because the closure of peripheral varicose veins is easier
after the elimination of large varicose veins.3 In the case of tele-
angiectasia, a 0.5% polidocanol solutionwas administered, whereas
reticular veins were obliterated with a 0.5% or 1% polidocanol
solution and varicose veins with a 2% polidocanol solution. The
polidocanol solution was injected using a 1-ml syringe with
a 29G  1/200 needle. The Section Ambulatoire des Varices avec
Sclérothérapie (SAVAS) method,2 which is a combination of surgeryTable 2
The results of the therapy used to remove hyperpigmentation.
Parameters Before therapy [mm]
Min Max Me x
Thickness of the dermis 1.03 1.92 1.48 1.49
Thickness of the subcutaneous tissue 5.70 16.46 11.11 11.42
Dermis echogenicity 10517 12811 11931 11766.29
Subcutaneous tissue echogenicity 47398 53568 51517 51424.67
Min - minimum value, Max - maximum value, Me - median, x - arithmetic mean, p - staand sclerotherapy, was used to obliterate the trunks of GSVs and
SSVs. A classical crossectomy, that is, the ligation and section of
a saphenofemoral junction (SFJ) or a saphenopopliteal junction
(SPJ) without the removal of the trunk of a GSV or SSV, was per-
formed in our study. Perforating veins were ligated and cut. A 3%
polidocanol foam was administered into the left trunk of the vein.
The foam was prepared earlier by Tessari’s method.3 The polido-
canol foam was injected through a thin latex catheter inserted into
the GSV by making a skin incision two-thirds of the way up the
shin. The injection of the foam into an SSVwas preceded bymaking
an incision in the region of the lateral ankle. Postprocedurally, all of
the patients wore II class compression stockings (23e32mmHg) for
an 8-week period. The diameters of the teleangiectasias, reticular
veins and collateral varicose veins were less than 1 mm, equal to
2e3 and 3e5mm, respectively. The greatest diameters of a GSV and
an SSV were 12 and 10 mm, respectively.
Ultrasonography
For ultrasound exams, a Toshiba Aplio device equipped with an
18-MHz linear head was used. Ultrasound examinations were
performed before the treatment, at each subsequent procedure and
after completing the therapy with constant settings. The following
parameters were assessed: the thickness of the dermis, the thick-
ness of the subcutaneous tissue, the echogenicity of the dermis and
the echogenicity of the subcutaneous tissue. The measurements of
the dermis and subcutaneous tissue thicknesses were obtained
based on the standard device software settings.
The dermis and subcutaneous tissue echogenicity values were
calculated by the summation of the pixel numbers in a deﬁned
range of brightness within the borders of the region of interest
(ROI).
Monitoring the therapywith the use of an ultrasoundwas aimed
at observing whether the veins subjected to sclerotherapy did or
did not undergo recanalisation, that is, if patency restoration did or
did not occur in the lumen.
IPL þ RF and dose adjustment
To eliminate the hyperpigmentation of the study subjects,
we used an IPL þ RF instrument, model S-E 3200, SUS Photon
Technology CO., China, with a head with a wavelength spectrum of
530e1200 nm. The planned therapy covered up to 10 singleAfter therapy [mm] t p
IQR Min Max Me x IQR
0.340 1.29 1.87 1.48 1.52 0.330 0.66 .519
5670 6.47 16.30 11.69 11.53 5590 0.29 .778
631 11204 12965 12243 12192.90 327 3.79 <.001
1037 46835 50930 49710 49389.48 1063 6.78 <.001
tistically signiﬁcant level for Student’s t-test, IQR - interquartile range.
Figure 1. Echogenicity of the dermis and the subcutaneous tissue: A-before treatment, B-after treatment.
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number of procedures was dependent on the characteristics of the
changes occurring in the skin (the average was seven treatments)
(Table 1). If hyperpigmentation regressed earlier, the therapy was
terminated accordingly (Table 1). Initial therapeutic parameters
were established based on the skin phototypes (according to the
Fitzpatrick’s scale)22 and the parameters recommended by the
manufacturer of the device for the elimination of hyperpigmenta-
tion after sun exposure. To verify that the initial parameter settings
were not too high (did not cause skin burns), a ‘trial’ was conducted.
This trial involved the application of IPL þ RF to a small hyperpig-
mented skin area; if during a 24-h period, no lesions appeared on
the skin surface, that is, a burn and/or severe erythema, the series of
procedures was started. The basis for an elevation of the dose was
a lack of change in the ultrasonography (US) image and in pictures
(the area of hyperpigmentation did not change in its dimensions,
and it did not get lighter or darker) that had been taken before the
therapy and approximately 30 days after the start of the IPL þ RF
procedure. Dermis echogenicity, which is considered to be a useful
parameter for analysing changes in the skin, the appearance of
respective skin layers and the borderline that separated them
were carefully analysed.23,24 According to the literature, we
assumed that if the use of IPL þ RF caused collagen restoration in
the dermis,17e19,25,27 then provided that the dose was adequately
adjusted, an increase in dermis echogenicity should have taken
place. In turn, these changes should be reﬂected in the ultrasound
images in terms of dermis growth (Table 1).
The ultrasonographic assessment of the performance of the
IPL þ RF procedure was initiated by the application of a thin gel
layer onto the hyperpigmented area. The gel provided a better
adherence of the applicator to the skin and normal light beam
transmission. Next, the IPL þ RF applicators were applied side by
side onto the overcoloured area, emitting light and radio waves.
During the procedure, the eyes of the patients and the staff were
protected by wearing special goggles.
In addition, photographic documentation was made using
a camera, a Canon 550D with a Canon EF 50 mm f/2.5 lens, with the
macro on. After ﬁnishing the therapy, all of the patients were asked
to ﬁll in a questionnaire regarding the level of their satisfaction
with the therapy.
Thedata collectedwere analysedby three independent researchers.
All of the women had been informed about the type and the aim
of the study and signed an informed consent form.Statistical analysis
Statistical analyses were performed using the Statistica 8 soft-
ware. The ShapiroeWilk test was applied, and the study samplewas found to have a normal distribution. Then, Student’s t-test and
a univariate analysis of variance (ANOVA) for dependent groups
were used. A statistically signiﬁcant level was assumed to be
a ¼ 0.05.Results
The detailed analysis of the ultrasonographic images demon-
strates that the pictures of hyperpigmented skin are different from
the pictures of healthy skin. A characteristic feature of an US
hyperpigmentation image was a blurred boundary between the
dermis and the subcutaneous tissue. Before beginning the therapy,
such an US hyperpigmentation image was present in 17 out of the
21 women studied, which represented 80.95% of the study sample.
The US examinations that were performed during the treatment
revealed the gradual differentiation of the dermis and the subcu-
taneous tissue. Moreover, a border between them started to
become visible while the US skin image gradually began to
resemble the image of the healthy skin. Once the IPL þ RF therapy
was ﬁnished, a blurred border between the subcutaneous tissue
and the dermis was still observed in only two individuals. The
changes in the US images occurred concomitantly with perceptible
changes on the skin surface. According to the analysis of the
ultrasound images conducted by the three independent investiga-
tors, the changes due to hyperpigmentation became less visible in
the US images (regressed) and a visible borderline developed
between the dermis and the subcutaneous tissue. In two individ-
uals, after the end of the IPL þ RF treatment, a clear separation of
the dermis from the subcutaneous tissue was not visible in their US
images; the hyperpigmentation became lighter but did not regress
completely.
Changes occurring in the skinwere also revealed by the analysis
of the data describing the two studied parameters, that is, the
echogenicity of the dermis and the echogenicity of the subcuta-
neous tissue (Table 2). Due to the therapy that was used, increases
in dermis echogenicities were recorded. Fig. 1 shows an example of
this where the mean echogenicity of the dermis increased from
11766.76 pixels to 12192.90 pixels following treatment. This
difference was statistically signiﬁcant at the level of p < 0.001
(Table 2). Prior to the start of the IPLþ RF therapy, the subcutaneous
tissue in hyperpigmented areas was characterised by a higher
echogenicity in all of the studied females. The mean echogenicities
of the subcutaneous tissue before and after the IPL þ RF therapy
were signiﬁcantly reduced (p < 0.001; Table 2). In addition,
this tissue became more and more hypoechogenous in the US
images as well (Fig. 1). In agreement with our study results, no
statistically signiﬁcant changes were found in terms of the dermis
and subcutaneous tissue thicknesses prior to and following the
Table 3
Comparison of the results for different patient groups distinguished on the basis of the CEAP classiﬁcation.
Parameters Before therapy [x] After therapy [x]
C1
n ¼ 7
C2
n ¼ 10
C3
n ¼ 4
F p C1
n ¼ 7
C2
n ¼ 10
C3
n ¼ 4
F p
Thickness of the dermis 1474 1430 1643 1118 0.349 1541 1469 1598 0.729 0.496
Thickness of the subcutaneous tissue 11.207 11.591 11.385 0.0267 0.974 10.36 11.882 12.705 0.887 0.429
Dermis echogenicity 11899.143 11702.100 11694.250 0.317 0.732 12308 12045.4 12360.25 1700 0.211
Subcutaneous tissue echogenicity 50925.143 51369.6 52436.5 1867 0.183 49078.714 49519.7 49607.75 0.409 0.670
C1, C2 and C3 - groups of patients according to the CEAP classiﬁcation, n - abundance, x - arithmetic mean, F - ANOVA (analysis of variance) result, p - level of statistical
signiﬁcance.
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therapy.
Due to the fact that the research sample was diverse and
hyperpigmentation arose after the closing of the blood vessels of
different diameters, the sample was divided into smaller groups
according to the CEAP classiﬁcation to determine whether there
were statistically signiﬁcant differences among the groups for each
parameter before the start of treatment and after its completion
(Table 3). The analysis showed no statistically signiﬁcant differ-
ences among the groups. This is not surprising given the small
numbers and the ﬁnding requires conﬁrmation in a larger study.
Themajority of individuals declared that the appearance of their
legs was important to them. Before starting the IPL þ RF therapy,
85.71% declared that their legs were ugly, but only one person
(4.67%) made the same declaration after the treatment. The average
level of patient satisfaction (scale 0e10; 0 ¼ not very satisﬁed,
10 ¼ very satisﬁed) was 8.71.
In summary, from the obtained results, we conclude that
a reduction in hyperpigmentation has taken place in all of theFigure 2. Permanent post-sclerotherapy hyperpigmentation: A-before treatwomen studied as a result of the therapy used. In 90.48% of the
patients, a complete regression of hyperpigmentation occurred
because of IPL þ RF treatment (Fig. 2). After the end of the therapy,
the skin areas formerly affected by hyperpigmentation did not
differ from the hyperpigmentation-free areas of the neighbouring
skin. In the case of 9.52% women, the hyperpigmentation became
lighter, and its area diminished; however, it did not regress
completely (Fig. 3). No IPL þ RF post-therapeutic complications
were discovered in the sample of women treated.
Discussion
The value of sclerotherapy as a therapeutic method for removing
unwanted blood vessels is unquestionable.16 Unfortunately, it is
very difﬁcult to remove the permanent post-sclerotherapy hyper-
pigmentation that may arise as a result of the procedure.11,13 Hae-
mosiderin plays a key role in the formation of hyperpigmentation.
It is a water insoluble, crystalline proteineiron complex that
accumulates in cells and extracellular matrices.26 Therefore, toment, B-complete regression of hyperpigmentation after 5 treatments.
Figure 3. Permanent post-sclerotherapy hyperpigmentation: A-before treatment, B-partial regression of hyperpigmentation after 10 treatments.
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siderin to provide an improved appearance of the skin, which is
dependent on the presence of collagen.17 Such a therapeutic
approach will bring a satisfactory aesthetic outcome to patients. As
shown in our studies, a therapy composed of a series of IPL þ RF
procedures can achieve the reduction or even total elimination of
hyperpigmentation.
The results of the tests conducted by Goldman8 showed that
haemosiderin accumulates up to 2.8 mm below the granular layer.
Therefore, the use of an IPL, which emits waves from 530 to
1200 nm to eliminate hyperpigmentation, can access the accumu-
lated haemosiderin, and the light waves that are generated may
penetrate up to 5 mm into the skin.27 In addition, haemosiderin
absorbs light of 694 nm wavelength particularly well.11 The
concomitant use of IPL þ RF may also have a beneﬁcial impact on
the obtained results. With their use in combination, the effective-
ness of the procedure may increase,17 in addition to using lower
parameter settings, compared with the effectiveness when using
only one energy type. Concomitant use of IPL þ RF causes the
procedure to be safer and reduces the number of potential
complications (burnings and erythema).16,17 In addition, in favour
of the use of the combined IPL þ RF technology, it is more effective
than the use of IPL alone in improving skin appearance.17 Bitter and
Mulholland19 demonstrated that IPL þ RF therapy was effective for
the removal of solar lentigo and other forms of hyperpigmentation
in 78% of their patients. The authors also reported that 97% of
subjects, in whom both therapeutic alternatives were tried, that is,
IPL þ RF and IPL alone, found that the IPL þ RF therapy was more
effective than the use of IPL alone. The results of the combined
therapy are seen more rapidly, and it is more comfortable for
a patient.17
An extremely useful tool for the monitoring of the therapy
described herein was the application of US to the skin. This was animportant use of this tool because nobody had previously removed
post-sclerotherapy hyperpigmentation by means of IPL þ RF
therapy. Owing to the use of US, we were able to monitor changes
occurring in the skin, and thus, we were not conﬁned to a solely
photography-based skin evaluation. Moreover, the use of US
enabled us to manage the dose of IPL þ RF applied. Dermis
echogenicity was the most useful parameter in the US studies. We
believe that the increase in dermal echogenicity is the result of
collagen synthesis. Collagen restoration was promoted by the
application of light pulses and radio waves. The dermis layer,
stimulated for reconstruction, likely exerted a positive reparative
effect on the appearance of the hyperpigmented skin area. Our
results are consistent with the ﬁndings of other authors.23,24 Our
study also found some variability in the echogenicities of the
subcutaneous tissue. The echogenicity of this layer decreased after
the termination of therapy. According to other authors’ works, an
elevated echogenicity of the subcutaneous tissue can be observed
during inﬂammation.28 Unfortunately, the cases described in the
literature cover inﬂammatory states of different aetiologies. Thus,
we are currently unable to make an unambiguous interpretation
of this result. We presume that, perhaps, as in the case of chronic
venous insufﬁciency, a chronic inﬂammation that is stimulated
and sustained by haemosiderin occurs in the subcutaneous
tissue.26 As a result of the changes triggered by a series of IPL þ RF
procedures, three layers may be distinguished in the US skin
images, that is, the epidermis, the dermis and the subcutaneous
tissue, which correspond to the images of healthy skin.1921
Consistent with the obtained results, after a series of 10 proce-
dures, we failed to achieve total regression of hyperpigmentation
in only 2 of the 21 cases. One can presume that the following
factors may have inﬂuenced the persistence of the status quo: the
hyperpigmentation dimensions linked to the type of sclerosing
agent used for the sclerotherapy, the concentration of the
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of the obliterated vessels, the skin phototype, the settings of the
procedural parameters and the number of procedures. In one of
the patients who had phototype III skin, the hyperpigmentation
did not regress; therefore, the IPL þ RF doses were low. In another
patient, an overcolouring appeared after GSV sclerotherapy (9 mm
in diameter). In that case, for the initial four procedures, we found
it difﬁcult to adjust the IPL þ RF dose because no changes were
recorded either in the USs image or on the surface of the skin. A
gradual regression of the hyperpigmentation was witnessed only
after the next few procedures.
This paper describes our experiences connected to the elimi-
nation of post-sclerotherapy hyperpigmentation by means of
IPL þ RF therapy. Considering the results, further studies on the
issue are necessary to determine the best possible parameter
settings for the use of IPL þ RF to eliminate haemosiderin hyper-
pigmentation. An in-depth understanding of the usefulness of US in
terms of skin studies also deserves additional scientiﬁc attention.
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